Vaccine News and Research

Latest Vaccine News and Research

Expert questions validity of genetic testing patents

Molecular Pathologist-Attorney Roger D. Klein in a letter published in the February 15, 2007 issue of the New England Journal of Medicine questioned the validity of patents often used to prevent clinical laboratories from performing certain genetic tests.

20 Feb 2007

Thimerosal to be discussed at Wednesday's CDC meeting

The Advisory Committee on Immunization Practices (ACIP) will meet this week at the CDC in Atlanta. Thimerosal, a controversial mercury-based vaccine preservative, is scheduled to be discussed Wednesday morning at 10:55 am.

19 Feb 2007

Search for vaccine to prevent Chlamydia

It's the most common bacteria-related sexually transmitted disease in the United States, so researchers at The University of Texas at San Antonio's South Texas Center for Emerging Infectious Diseases (STCEID) and The University of Texas at San Antonio Health Science Center have partnered to discover a vaccine that will prevent Chlamydia.

19 Feb 2007

Scientists discover vulnerable area on HIV that could lead to development of HIV/AIDS vaccine

Scientists on Wednesday announced they had identified a vulnerable area on HIV that might be susceptible to antibodies and could prevent the virus from infecting human cells, Reuters Health reports. The findings are published in the Feb. 15 issue of the journal Nature.

19 Feb 2007

The present and future for influenza vaccines

The near inevitability that influenza will explode into a pandemic in the coming few years has kept researchers searching for a way to prevent the worst effects of infection. The ultimate prize is a highly effective vaccine that could be produced and deployed rapidly.

18 Feb 2007

Novel spray method for delivering tuberculosis vaccine

Bioengineers and public health researchers at Harvard University have developed a novel spraying method for delivering the most common tuberculosis (TB) vaccine, providing a new low-cost and scaleable technique that offers needle-free delivery and greater stability at room temperature than existing methods.

18 Feb 2007

Promising results on avian influenza vaccines

Experts meeting this week at the World Health Organization (WHO) on advances in pandemic influenza vaccine development reported encouraging progress.

18 Feb 2007

Nasal spray vaccine gives kids more protection from flu than shots

In a new study involving thousands of children across the world, a new version of the nasal spray vaccine FluMist has been found to be more effective at preventing influenza than traditional flu shots.

18 Feb 2007

Body Shop founder Roddick reveals she has Hepatitis C

Anita Roddick the founder of the Body Shop has revealed she is suffering from the disease Hepatitis C.

14 Feb 2007

Warning over new rotavirus vaccine RotaTeq

Reports in the United States of cases of infants suffering a serious bowel condition as a result of taking a new vaccine against the rotavirus, have prompted the U.S. Food and Drug Administration (FDA) to issue a warning about the drug.

14 Feb 2007

Seasonal flu vaccine offers some protection from H5N1

The yearly influenza vaccine that health officials urge people to get each fall might also offer certain individuals some cross protection against the H5N1 virus commonly known as bird flu, according to investigators at St. Jude Children's Research Hospital.

13 Feb 2007

Texas lawmakers ask Gov. Perry to rescind order mandating HPV vaccination for girls entering sixth grade

Thirty-two Texas lawmakers last Thursday sent a letter to Gov. Rick Perry (R) reiterating their plea for him to rescind an executive order that would mandate vaccination against human papillomavirus for girls entering the sixth grade, the AP/Dallas Morning News reports.

13 Feb 2007

Actions taken on HPV vaccine proposals in Alabama, Louisiana, Utah, Washington

The following highlights recent news of state actions on human papillomavirus vaccine proposals. Merck's HPV vaccine Gardasil and GlaxoSmithKline's HPV vaccine Cervarix in clinical trials have been shown to be 100% effective in preventing infection with HPV strains 16 and 18, which together cause about 70% of cervical cancer cases.

13 Feb 2007

G7 nations plan to adopt vaccine purchase plan for diseases such as HIV/AIDS, TB, Malaria

The Group of Seven industrialized nations on Friday plans to sign an agreement to provide $1.5 billion to develop vaccines for diseases -- including HIV/AIDS, TB and malaria -- that largely affect developing countries, the government of Italy announced on Tuesday, Reuters reports.

13 Feb 2007

Wealthy nations launch vaccine purchase plan for diseases such as HIV/AIDS, TB, Malaria

Officials from a group of wealthy nations on Friday launched a $1.5 billion plan to provide and develop vaccines for diseases -- including HIV/AIDS, tuberculosis and malaria -- that largely affect developing countries, the New York Times reports.

13 Feb 2007

Nanoparticle boost for antitumor vaccines

Researchers have known for some time that certain sequences of synthetic DNA induce potent immune responses when injected into animals and humans.

12 Feb 2007

British bird flu - who's to blame?

The Hungarian Agriculture Ministry has admitted that turkey meat from a plant near the site of a Hungarian bird flu outbreak was sold to various parts of Europe including Britain.

12 Feb 2007

Vaccine against group B Streptococci

The search for a vaccine against group B streptococci Group B streptococci are one of the leading causes of infection in newborn infants, causing pneumonia, septicaemia or meningitis.

12 Feb 2007

Changes in breast cancer management

Aggressive research currently underway brings hope of dramatic advances in breast cancer management, according to a new review.

12 Feb 2007

South Africa starts major HIV/AIDS vaccine trial

The launch of the first large-scale study to evaluate a candidate HIV vaccine on the African continent was announced today by study collaborators in the United States and South Africa. The trial will involve up to 3,000 participants at five sites throughout South Africa and is expected to continue for four years.

11 Feb 2007